Lidocain Braun

Lidocaine, the active ingredient in Lidocain Braun, is a local anesthetic presented as a sterile solution for epidural, intradermal and subcutaneous use. It provides reversible nerve block to facilitate pain‑free procedures in surgical, obstetric and minor dermatologic settings.

GNH USA supplies Lidocain Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocain Braun is a local anesthetic indicated for procedures involving the peripheral and central nervous system pathways.

- Epidural anesthesia: produces segmental loss of sensation for obstetric or surgical procedures. - Intradermal anesthesia: numbs the skin to allow painless minor surgeries or diagnostic tests. - Subcutaneous anesthesia: facilitates pain‑free injections and minor tissue excisions.

Lidocain Braun may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Local irritation at the injection site: redness or mild swelling. - Transient numbness or tingling: temporary sensory changes. - Burning or stinging sensation: brief discomfort during administration. - Dizziness or light‑headedness: mild systemic effect. - Headache: occasional post‑procedure symptom. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Allergic reactions: rash, urticaria, or anaphylaxis. - Systemic toxicity: seizures, cardiac arrhythmias, or hypotension. - Methemoglobinemia: reduced oxygen‑carrying capacity of blood. - Respiratory depression: difficulty breathing. - Severe hypotension: sudden drop in blood pressure. - Cardiovascular collapse: life‑threatening circulatory failure.

When using Lidocain Braun, clinicians should observe specific safety measures.

- Allergy assessment: verify no known hypersensitivity to lidocaine or amide‑type anesthetics. - Minimum effective dose: use the lowest concentration that achieves adequate anesthesia. - Cardiovascular monitoring: observe heart rate and rhythm during epidural administration. - Hepatic impairment: exercise caution in patients with severe liver disease. - Pediatric use: adjust dosing carefully and monitor for signs of toxicity. - Store at ambient temperature: keep in original container, protect from moisture and light.

Lidocain Braun can interact with other medications, requiring careful management.

Major Interactions (Avoid): - Amiodarone: may increase plasma lidocaine levels, raising toxicity risk. - Class I antiarrhythmics (e.g., quinidine): additive cardiac conduction effects. - Strong CYP3A4 inhibitors (e.g., erythromycin, clarithromycin): elevate lidocaine concentrations.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce lidocaine efficacy. - Central nervous system depressants (e.g., benzodiazepines, opioids): enhance sedative effects. - Diuretics (e.g., furosemide): alter plasma protein binding, affecting free drug levels.